First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

H. Namkoong, T. Asakura, M. Ishii, S. Yoda, Katsunori Masaki, T. Sakagami, Eisuke Iwasaki, Y. Yamagishi, Takanori Kanai, Tomoko Betsuyaku, Naoki Hasegawa

Research output: Contribution to journalArticle

Abstract

This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

Original languageEnglish
Pages (from-to)4-6
Number of pages3
JournalNew Microbes and New Infections
Volume27
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Mycobacterium avium
Mycobacterium Infections
Obstructive Jaundice
Autoantibodies
Jaundice
Therapeutics

Keywords

  • Anti–interferon gamma (IFN-γ) autoantibody
  • disseminated Mycobacterium aviumcomplex infection
  • hepatobiliary infection
  • jaundice
  • Mycobacterium aviumcomplex (MAC)

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies. / Namkoong, H.; Asakura, T.; Ishii, M.; Yoda, S.; Masaki, Katsunori; Sakagami, T.; Iwasaki, Eisuke; Yamagishi, Y.; Kanai, Takanori; Betsuyaku, Tomoko; Hasegawa, Naoki.

In: New Microbes and New Infections, Vol. 27, 01.01.2019, p. 4-6.

Research output: Contribution to journalArticle

@article{81b814b214e4452b98685d6c3c494790,
title = "First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies",
abstract = "This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.",
keywords = "Anti–interferon gamma (IFN-γ) autoantibody, disseminated Mycobacterium aviumcomplex infection, hepatobiliary infection, jaundice, Mycobacterium aviumcomplex (MAC)",
author = "H. Namkoong and T. Asakura and M. Ishii and S. Yoda and Katsunori Masaki and T. Sakagami and Eisuke Iwasaki and Y. Yamagishi and Takanori Kanai and Tomoko Betsuyaku and Naoki Hasegawa",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.nmni.2018.10.001",
language = "English",
volume = "27",
pages = "4--6",
journal = "New Microbes and New Infections",
issn = "2052-2975",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti–interferon-gamma autoantibodies

AU - Namkoong, H.

AU - Asakura, T.

AU - Ishii, M.

AU - Yoda, S.

AU - Masaki, Katsunori

AU - Sakagami, T.

AU - Iwasaki, Eisuke

AU - Yamagishi, Y.

AU - Kanai, Takanori

AU - Betsuyaku, Tomoko

AU - Hasegawa, Naoki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

AB - This study describes a patient who experienced hepatobiliary Mycobacterium avium infection associated with neutralizing anti–interferon gamma (IFN-γ) autoantibodies during treatment for disseminated M. avium disease. Hepatobiliary M. avium infection should be considered in jaundiced patients with neutralizing anti–IFN-γ autoantibodies, including those receiving antimycobacterial therapy for disseminated M. avium disease.

KW - Anti–interferon gamma (IFN-γ) autoantibody

KW - disseminated Mycobacterium aviumcomplex infection

KW - hepatobiliary infection

KW - jaundice

KW - Mycobacterium aviumcomplex (MAC)

UR - http://www.scopus.com/inward/record.url?scp=85056726089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056726089&partnerID=8YFLogxK

U2 - 10.1016/j.nmni.2018.10.001

DO - 10.1016/j.nmni.2018.10.001

M3 - Article

VL - 27

SP - 4

EP - 6

JO - New Microbes and New Infections

JF - New Microbes and New Infections

SN - 2052-2975

ER -